Linda Beauclair, MD
Primary Axis:
Mental Illness and Addiction
Email:
Email contact form Research Focus:
Investigation of new treatments for schizophrenia, depression, tardive dyskinesia, anxiety, panic disorder, obsessive compulsive disorder.Psychopharmacology, antipsychotics, antiepileptics, antidepressants, tardive dyskinesia, anxiolytics.
Keywords:
Psychopharmacology, antipsychotics, antiepileptics, antidepressants, tardive dyskinesia, anxiolytics.
Location:
Royal Victoria Hospital Publications:
Desmarais JE, Beauclair L, Margolese HC. Switching from brand-name to generic psychotropic medications: a literature review. CNS Neuroscience and Therapeutics, no. doi: 10-111 1/1755-5949.2010.00210.x; 2010
Margolese HC, Wolf Y, Desmarais JE, Beauclair L: Loss of response after switching from brand-name to generic formulations: 3 cases and a discussion of key clinical considerations when switching. Int Clin Psychopharmacology; 25(3):180-182; May 2010
Beauclair L, Chue P, McCormick J, Camacho F, Lam A, Luong D. Impact of Risperidone Long-Acting Injectable on Hospitalization and Medication Use In Canadian Patients with Schizophrenia. Journal of Medical Economics; 10: 427–442; 2007
